ArticleEuropean journal of pediatrics2026
Impact of a multidisciplinary care pathway on follow-up and emergency department utilisation in paediatric musculoskeletal infections.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
To evaluate whether implementation of a multidisciplinary care pathway was associated with changes in unplanned emergency department (ED) visits in children with musculoskeletal infections, and to assess its impact on readmissions, reoperations, and key process measures. We conducted a single-centre quality-improvement study of children with septic arthritis (SA) or acute osteomyelitis (AO) treated at a tertiary paediatric hospital in Canada. A pathway introduced in September 2021 standardised C-reactive protein (CRP) monitoring, discharge documentation, and coordinated in-person and virtual follow-up. Consecutive post-pathway patients (September 2021-July 2022) were compared with a pre-pathway cohort (June 2018-August 2021). The primary outcome was unplanned ED visits within three months of discharge. Secondary outcomes included readmission, reoperation, and predefined process measures. Analyses used regression models and statistical process control (SPC) p-charts. A total of 122 children were included (77 pre-pathway, 45 post-pathway). Median age was similar between groups (4.0 vs 6.5 years, p = 0.25). Unplanned ED visits decreased from 28.6% to 17.8% (RR 0.62, 95% CI 0.30-1.28; p = 0.18). However, this difference was not statistically significant, and SPC analysis demonstrated common-cause variation. Pathway phase was not independently associated with ED visits after adjustment (OR 1.46, 95% CI 0.53-4.04; p = 0.47). Readmissions and reoperations were unchanged. Several process measures improved, including day-3 CRP measurement (61.0 vs 86.7%; p = 0.003), number of follow-up visits (median 3 vs 5; p < 0.001), and fewer missed appointments (median 1 vs 0; p < 0.001). LEVEL OF EVIDENCE: Level III (Prospective comparative quality improvement study).
conclusionImplementation of a multidisciplinary care pathway was associated with improved process reliability and follow-up adherence. Although unplanned ED visits were lower in the post-pathway cohort, this difference did not reach statistical significance. These findings support coordinated, team-based approaches to optimise care processes for paediatric musculoskeletal infections. WHAT IS KNOWN: • Children with septic arthritis and acute osteomyelitis frequently have unplanned emergency department visits after discharge, despite relatively low readmission and reoperation rates. • Care delivery often varies across the inpatient-outpatient continuum, with inconsistent inflammatory marker monitoring and limited multidisciplinary coordination. WHAT IS NEW: • Implementation of a multidisciplinary care pathway was associated with improved CRP monitoring, follow-up adherence, and appointment reliability. • Although unplanned ED visits were numerically lower post-pathway, this difference did not reach statistical significance; however, process reliability and continuity of care improved without increases in readmissions or reoperations.
Indexed as
Identifiers
41806202What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.